📊 CC Key Takeaways
Is Chemours Co (CC) a Good Investment?
Chemours is facing severe operational distress with negative operating and net income despite stable revenue, indicating fundamental business deterioration. The company's extremely high leverage (16.4x debt-to-equity) combined with negative interest coverage and minimal profitability creates significant financial risk and sustainability concerns. Even positive free cash flow of $51M is insufficient to service $4.1B in long-term debt or address the underlying operational profitability crisis.
Chemours' fundamentals are under significant pressure: revenue is essentially flat, but margins have deteriorated sharply into operating and net losses, while ROE and interest coverage indicate a severely strained capital structure. The company still generates positive operating cash flow and modest free cash flow, and liquidity is not immediately distressed, but weak profitability and very high leverage materially reduce financial flexibility. Until margins, earnings quality, and balance sheet strength improve, the fundamental profile remains unattractive.
Why Buy Chemours Co Stock? CC Key Strengths
- Positive operating cash flow of $264M provides near-term liquidity despite net losses
- Current ratio of 1.78x indicates adequate short-term liquidity to meet obligations
- Free cash flow of $51M demonstrates some cash generation capacity from operations
- Positive operating cash flow and modest free cash flow despite net losses
- Adequate near-term liquidity with a 1.78x current ratio and $670M in cash
- Revenue has remained relatively stable year over year
CC Stock Risks: Chemours Co Investment Risks
- Severe negative profitability with -6.6% net margin and -$386M net income indicates structural operational failure
- Extreme leverage at 16.4x debt-to-equity with $4.1B long-term debt against only $250M equity creates default risk
- Negative interest coverage of -1.0x means operating income cannot cover debt service, threatening financial stability
- Negative ROE of -154.4% and ROA of -5.2% show value destruction for shareholders and asset base
- Operating margin of -4.8% indicates core business is unprofitable before financing costs
- Negative operating margin and net margin indicate poor earnings quality and weak cost absorption
- Extremely high leverage with debt/equity of 16.40x and only $250M of equity
- Negative interest coverage suggests earnings are insufficient to support debt burden
Key Metrics to Watch
- Path to operating profitability and positive operating margins
- Debt reduction progress and debt-to-equity ratio improvement
- Interest coverage ratio trajectory and debt service sustainability
- Net income recovery and return to profitability
- Free cash flow sustainability and cash burn rate
- Operating margin and gross margin recovery
- Free cash flow generation relative to debt and interest obligations
Chemours Co (CC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 0.9% FCF margin may limit capital allocation flexibility.
CC Profit Margin, ROE & Profitability Analysis
CC vs Materials Sector: How Chemours Co Compares
How Chemours Co compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Chemours Co Stock Overvalued? CC Valuation Analysis 2026
Based on fundamental analysis, Chemours Co shows some fundamental concerns relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Chemours Co Balance Sheet: CC Debt, Cash & Liquidity
CC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Chemours Co's revenue has remained relatively flat over the 5-year period, with a 4% decline. The most recent EPS of $-1.70 indicates the company is currently unprofitable.
CC Revenue Growth, EPS Growth & YoY Performance
CC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.5B | -$32.0M | $-0.22 |
| Q2 2025 | $1.6B | $60.0M | $0.39 |
| Q1 2025 | $1.4B | -$4.0M | $-0.03 |
| Q3 2024 | $1.5B | $12.0M | $0.08 |
| Q2 2024 | $1.5B | $70.0M | $0.46 |
| Q1 2024 | $1.4B | $52.0M | $0.34 |
| Q3 2023 | $1.5B | $20.0M | $0.13 |
| Q2 2023 | $1.6B | $201.0M | $1.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Chemours Co Dividends, Buybacks & Capital Allocation
CC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Chemours Co (CIK: 0001627223)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CC
What is the AI rating for CC?
Chemours Co (CC) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CC's key strengths?
Claude: Positive operating cash flow of $264M provides near-term liquidity despite net losses. Current ratio of 1.78x indicates adequate short-term liquidity to meet obligations. ChatGPT: Positive operating cash flow and modest free cash flow despite net losses. Adequate near-term liquidity with a 1.78x current ratio and $670M in cash.
What are the risks of investing in CC?
Claude: Severe negative profitability with -6.6% net margin and -$386M net income indicates structural operational failure. Extreme leverage at 16.4x debt-to-equity with $4.1B long-term debt against only $250M equity creates default risk. ChatGPT: Negative operating margin and net margin indicate poor earnings quality and weak cost absorption. Extremely high leverage with debt/equity of 16.40x and only $250M of equity.
What is CC's revenue and growth?
Chemours Co reported revenue of $5.8B.
Does CC pay dividends?
Chemours Co pays dividends, with $78.0M distributed to shareholders in the trailing twelve months.
Where can I find CC SEC filings?
Official SEC filings for Chemours Co (CIK: 0001627223) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CC's EPS?
Chemours Co has a diluted EPS of $-2.57.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Chemours Co has a SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CC stock overvalued or undervalued?
Valuation metrics for CC: ROE of -154.4% (sector avg: 14%), net margin of -6.6% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy CC stock in 2026?
Our dual AI analysis gives Chemours Co a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CC's free cash flow?
Chemours Co's operating cash flow is $264.0M, with capital expenditures of $213.0M. FCF margin is 0.9%.
How does CC compare to other Materials stocks?
Vs Materials sector averages: Net margin -6.6% (avg: 10%), ROE -154.4% (avg: 14%), current ratio 1.78 (avg: 1.6).
Is Chemours Co carrying too much debt?
CC has a debt-to-equity ratio of 16.40x, which is above the Materials sector average of 0.6x. However, the current ratio of 1.78 suggests adequate short-term liquidity.